|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 9.23 CNY | -1.81% |
|
-1.70% | -39.04% |
InventisBio Co., Ltd. reported earnings results for the nine months ended September 30, 2023. For the nine months, the company reported sales was CNY 127.17 million. Revenue was CNY 127.17 million.
Net loss was CNY 241.26 million compared to CNY 385 million a year ago. Basic loss per share from continuing operations was CNY 0.42 compared to CNY 0.79 a year ago. Diluted loss per share from continuing operations was CNY 0.42 compared to CNY 0.79 a year ago.
| 1st Jan change | Capi. | |
|---|---|---|
| -39.04% | 736M | |
| +9.58% | 115B | |
| +12.41% | 107B | |
| -3.11% | 21.6B | |
| -12.38% | 22.31B | |
| -5.29% | 19.19B | |
| -3.35% | 18.23B | |
| -38.57% | 17.62B | |
| +7.51% | 14.26B | |
| +35.67% | 12.37B |
INVENTISBIO CO., LIMITED 
